Showing results (91-100 of 194) with videos related to
Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapyAndrew Reid, Wolfgang Stöhr, A Sarah Walker, et al.The Lancet. HIV|October 5, 2018
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control studySeth C Inzaule, Raph L Hamers, Marc Noguera-Julian, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and ZimbabweA Sarah Walker, Andrew J Prendergast, Peter Mugyenyi, et al.Open Forum Infectious Diseases|August 13, 2025
Distinct Metabolic and Inflammation Signatures in Urban vs Rural Ugandan Youth With HIV on DolutegravirSahera Dirajlal-Fargo, Shan Sun, Kate Ailstock, et al.AIDS Research and Human Retroviruses|January 23, 2018
Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Fred Kyeyune, et al.Plos One|September 19, 2015
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA TrialKatherine A Sutherland, Chris M Parry, Adele McCormick, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.Global Heart|April 25, 2018
A Human-Centered Approach to CV Care: Infrastructure Development in UgandaChristopher T Longenecker, Ankur Kalra, Emmy Okello, et al.International Immunopharmacology|November 9, 2004
Identification of a host gene subset related to disease prognosis of HIV-1 infected individualsKazushi Motomura, Nobuaki Toyoda, Kazunori Oishi, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countriesPapa S Sow, Leander F Otieno, Emmanuel Bissagnene, et al.Pageof 20